Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Calvo

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Leukemia|November 17, 2022
Should we give oligomonocytic chronic myelomonocytic leukemia a higher prominence in the next WHO Classification of Haematolymphoid Tumors?Xavier Calvo
Haematologica|July 4, 2024
Acute myeloid leukemia at first relapse: approaching the precipiceXavier Calvo
Leukemia|February 28, 2018
(In)convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromesXavier Calvo, Lourdes Florensa, Leonor Arenillas
Genes|September 23, 2022
Causes and Pathophysiology of Acquired Sideroblastic AnemiaJuan Jose Rodriguez-Sevilla, Xavier Calvo, Leonor Arenillas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2017
Reply to M.A. LichtmanLeonor Arenillas, Xavier Calvo, Guillermo F Sanz, et al.
Cytometry. Part B, Clinical Cytometry|January 21, 2022
Dissecting the sCD3-CD4+ T-cell population: A valuable screening tool for angioimmunoblastic T-cell lymphomaJuan Jose Rodriguez-Sevilla, Ana Ferrer, Luis Colomo, et al.
International Journal of Laboratory Hematology|December 16, 2021
Morphological central nervous system differentiation syndrome in acute promyelocytic leukemia relapseJuan Jose Rodriguez-Sevilla, Xavier Calvo, Sara Garcia, et al.
Histology and Histopathology|February 20, 2019
The importance of adequate recognition of normal and dysplastic myelopoiesis for the diagnosis of myelodysplastic syndromesLourdes Florensa, Leonor Arenillas, Xavier Calvo, et al.
Cancers|April 9, 2020
Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell LymphomasIvonne Vazquez, Natalia Papaleo, Eugenia Garcia, et al.
Annals of Hematology|June 23, 2010
Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patientsAlejandra Martínez-Trillos, Anna Gaya, Margherita Maffioli, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Leukemia|November 17, 2022
Should we give oligomonocytic chronic myelomonocytic leukemia a higher prominence in the next WHO Classification of Haematolymphoid Tumors?Xavier Calvo
Haematologica|July 4, 2024
Acute myeloid leukemia at first relapse: approaching the precipiceXavier Calvo
Leukemia|February 28, 2018
(In)convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromesXavier Calvo, Lourdes Florensa, Leonor Arenillas
Genes|September 23, 2022
Causes and Pathophysiology of Acquired Sideroblastic AnemiaJuan Jose Rodriguez-Sevilla, Xavier Calvo, Leonor Arenillas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2017
Reply to M.A. LichtmanLeonor Arenillas, Xavier Calvo, Guillermo F Sanz, et al.
Cytometry. Part B, Clinical Cytometry|January 21, 2022
Dissecting the sCD3-CD4+ T-cell population: A valuable screening tool for angioimmunoblastic T-cell lymphomaJuan Jose Rodriguez-Sevilla, Ana Ferrer, Luis Colomo, et al.
International Journal of Laboratory Hematology|December 16, 2021
Morphological central nervous system differentiation syndrome in acute promyelocytic leukemia relapseJuan Jose Rodriguez-Sevilla, Xavier Calvo, Sara Garcia, et al.
Histology and Histopathology|February 20, 2019
The importance of adequate recognition of normal and dysplastic myelopoiesis for the diagnosis of myelodysplastic syndromesLourdes Florensa, Leonor Arenillas, Xavier Calvo, et al.
Cancers|April 9, 2020
Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell LymphomasIvonne Vazquez, Natalia Papaleo, Eugenia Garcia, et al.
Annals of Hematology|June 23, 2010
Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patientsAlejandra Martínez-Trillos, Anna Gaya, Margherita Maffioli, et al.
Pageof 6